Clinical trial
Clinical Study on the Safety and Efficacy of the ZIPPER™ Aortic Arch Stent-Graft System in the Treatment of Aortic Arch Dissection
NCT07170332 is registered in ClinicalTrials.gov with Hangzhou Endonom Medtech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study on the Safety and Efficacy of the ZIPPER™ Aortic Arch Stent-Graft System in the Treatment of Aortic Arch Dissection
- Lead sponsor
- Hangzhou Endonom Medtech Co., Ltd.
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 30, 2025
- Completion date
- September 30, 2032
- Enrollment
- 127 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
dissection of aortic arch